SOLICITATION NOTICE
66 -- ThermoFisher Scientific BPA - JOFOC - Equipment List
- Notice Date
- 5/23/2017
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- 08537
- Archive Date
- 6/22/2017
- Point of Contact
- William T. Brannen, Phone: 7704882084
- E-Mail Address
-
vwl0@cdc.gov
(vwl0@cdc.gov)
- Small Business Set-Aside
- N/A
- Description
- Equipment List Justification for Other Than Full and Open Competition The Centers for Disease Control and Prevention (CDC) National Center for Emerging and Zoonotic Infectious Diseases for (NCEZID) in Atlanta, Georgia, intends to negotiate a sole source Blanket Purchase Agreement (BPA) with ThermoFisher Scientific, Inc., under authority of Federal Acquisition Regulation (FAR) Subpart 6.302-1, Other Than Full and Open Competition procedures and FAR Part 13, Simplified Acquisition Procedures, for the acquisition of ThermoFisher Scientific for the molecular biology reagents, consumables and instruments to support surveillance, research, and the reference laboratory work done across the various CIOs within CDC.. The sequencing reagents and consumables in this acquisition are in a pre-configured format and will fit directly into the ThermoFisher Scientific sequencing instruments currently in use at CDC (government owned Applied Biosystems, Life Technologies and Ion Torrent brand instruments, including, but not limited to, 3100, 3130, 3730, 3500 Genetic Analyzer platforms, and Ion torrent sequencing platforms). These supplies and reagents plus the Invitrogen cloning reagents, pcr reagents and enzymes are covered by various patents. The sequencing reagents are manufactured under ISO 9001 and ISO 13485 and must pass stringent quality control checkpoints to achieve unmatched consistency in lot to lot stability. All service and support warranties CDC currently carries on genetic analyzers may be voided if off brand reagents are used because these may impact the integrity of the sequencer components. This is a notice of intent and is not a request for competitive quotes or proposals. No solicitation is available. Firms that believe they can meet the requirement are encouraged to identify themselves and provide a substantive statement with descriptive literature and any other supporting information to the Contracting Officer within 15 days of publication of this notice. All information received within 15 days of publication of this synopsis will be considered by the Government to determine if more than one firm can meet the Government's requirements and is capable of providing technically acceptable equipment, chemical reagents and services. Responses to this posting must be submitted in writing via e-mail only. A determination not to compete the described requirement based upon responses to this notice is solely within the discretion of the Federal Government. Information received will be considered solely for the purpose of determining whether or not to conduct a competitive procurement. Any questions or comments should be directed via e-mail ONLY to William Brannen at VWL0@cdc.gov. Thank you for your interest.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/08537/listing.html)
- Place of Performance
- Address: Contractors Address, United States
- Record
- SN04518567-W 20170525/170523235019-4dfd0bbe081d1a81d4f8c6b98b047a75 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |